Nutritional support in ventilatory failure

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Malnutrition has a well defined effect on pulmonary physiology and pulmonary dysfunction may lead to nutritional depletion. Nutritional support is used as a part of the routine therapeutic armamentarium for patients with acute and chronic respiratory insufficiency. Since nutrients have pharmacologic properties and physiologic actions, these have to be considered, and tailored to the type of pathophysiology and stage of respiratory failure. Status of respiratory drive, respiratory muscle strength, air trapping, parenchymal inflammation, body and lung water and circulatory competence are all relevant. Nutritional support increases metabolic demand and respiratory drive with progressive improvement in respiratory muscle and parenchymal function. Carbohydrate may increase CO2 production and RQ, especially in injured or septic patients, which may result in increased ventilatory demand. Intravenous fat emulsions are an accepted alternative substrate; recent work suggests that their quantity and quality may affect pulmonary vasomotor tone and pulmonary inflammation due to changes in eicosanoid metabolism. These properties may have implications to both severe chronic diseases (i.e. cystic fibrosis) and acute respiratory failure. Amino acid infusions, especially the BCAA-enriched formulas, result in a dose-dependent increase in ventilatory drive and response to hypercapnia; detrimental effects may occur in states with high respiratory drive. In acute phase, calories are supplied in the 1-1.2 REE range; once the patient has stabilized this is increased to 1.4-1.7 REE. Glucose is supplied in the lower range of the obligatory need (2-4 g · kg-1 · day-1) and lipid, which has an equivalent nitrogen-sparing effect, is infused 12-24 h daily to provide 50-60% of daily calories. Amino acids are infused at 1-2 g protein · kg-1 · day-1. A good response to a proper nutritional regimen in respiratory insufficiency is accompanied by diuresis and a rise in serum albumin in addition to normalization of respiratory drive and muscle endurance.

Original languageEnglish (US)
Title of host publicationNutritional support in organ failure: proceedings of the International Symposium. ICS836
EditorsT. Tanaka, A. Okada, T. Tanaka, A. Okada
PublisherElsevier Science Publishers B.V.
Pages131-136
Number of pages6
ISBN (Print)0444811613
StatePublished - 1990
EventThe International Symposium -
Duration: Nov 21 1988Nov 23 1988

Other

OtherThe International Symposium
Period11/21/8811/23/88

Fingerprint

Nutritional Support
Respiratory Insufficiency
Respiratory Muscles
Lung
Pneumonia
Intravenous Fat Emulsions
Amino Acids
Eicosanoids
Hypercapnia
Body Water
Diuresis
Muscle Strength
Cystic Fibrosis
Serum Albumin
Malnutrition
Mental Competency
Chronic Disease
Nitrogen
Air
Carbohydrates

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kvetan, V. (1990). Nutritional support in ventilatory failure. In T. Tanaka, A. Okada, T. Tanaka, & A. Okada (Eds.), Nutritional support in organ failure: proceedings of the International Symposium. ICS836 (pp. 131-136). Elsevier Science Publishers B.V..

Nutritional support in ventilatory failure. / Kvetan, Vladimir.

Nutritional support in organ failure: proceedings of the International Symposium. ICS836. ed. / T. Tanaka; A. Okada; T. Tanaka; A. Okada. Elsevier Science Publishers B.V., 1990. p. 131-136.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Kvetan, V 1990, Nutritional support in ventilatory failure. in T Tanaka, A Okada, T Tanaka & A Okada (eds), Nutritional support in organ failure: proceedings of the International Symposium. ICS836. Elsevier Science Publishers B.V., pp. 131-136, The International Symposium, 11/21/88.
Kvetan V. Nutritional support in ventilatory failure. In Tanaka T, Okada A, Tanaka T, Okada A, editors, Nutritional support in organ failure: proceedings of the International Symposium. ICS836. Elsevier Science Publishers B.V. 1990. p. 131-136
Kvetan, Vladimir. / Nutritional support in ventilatory failure. Nutritional support in organ failure: proceedings of the International Symposium. ICS836. editor / T. Tanaka ; A. Okada ; T. Tanaka ; A. Okada. Elsevier Science Publishers B.V., 1990. pp. 131-136
@inproceedings{14008d4ea58d4c5887d30c3bd12e1e99,
title = "Nutritional support in ventilatory failure",
abstract = "Malnutrition has a well defined effect on pulmonary physiology and pulmonary dysfunction may lead to nutritional depletion. Nutritional support is used as a part of the routine therapeutic armamentarium for patients with acute and chronic respiratory insufficiency. Since nutrients have pharmacologic properties and physiologic actions, these have to be considered, and tailored to the type of pathophysiology and stage of respiratory failure. Status of respiratory drive, respiratory muscle strength, air trapping, parenchymal inflammation, body and lung water and circulatory competence are all relevant. Nutritional support increases metabolic demand and respiratory drive with progressive improvement in respiratory muscle and parenchymal function. Carbohydrate may increase CO2 production and RQ, especially in injured or septic patients, which may result in increased ventilatory demand. Intravenous fat emulsions are an accepted alternative substrate; recent work suggests that their quantity and quality may affect pulmonary vasomotor tone and pulmonary inflammation due to changes in eicosanoid metabolism. These properties may have implications to both severe chronic diseases (i.e. cystic fibrosis) and acute respiratory failure. Amino acid infusions, especially the BCAA-enriched formulas, result in a dose-dependent increase in ventilatory drive and response to hypercapnia; detrimental effects may occur in states with high respiratory drive. In acute phase, calories are supplied in the 1-1.2 REE range; once the patient has stabilized this is increased to 1.4-1.7 REE. Glucose is supplied in the lower range of the obligatory need (2-4 g · kg-1 · day-1) and lipid, which has an equivalent nitrogen-sparing effect, is infused 12-24 h daily to provide 50-60{\%} of daily calories. Amino acids are infused at 1-2 g protein · kg-1 · day-1. A good response to a proper nutritional regimen in respiratory insufficiency is accompanied by diuresis and a rise in serum albumin in addition to normalization of respiratory drive and muscle endurance.",
author = "Vladimir Kvetan",
year = "1990",
language = "English (US)",
isbn = "0444811613",
pages = "131--136",
editor = "T. Tanaka and A. Okada and T. Tanaka and A. Okada",
booktitle = "Nutritional support in organ failure: proceedings of the International Symposium. ICS836",
publisher = "Elsevier Science Publishers B.V.",

}

TY - GEN

T1 - Nutritional support in ventilatory failure

AU - Kvetan, Vladimir

PY - 1990

Y1 - 1990

N2 - Malnutrition has a well defined effect on pulmonary physiology and pulmonary dysfunction may lead to nutritional depletion. Nutritional support is used as a part of the routine therapeutic armamentarium for patients with acute and chronic respiratory insufficiency. Since nutrients have pharmacologic properties and physiologic actions, these have to be considered, and tailored to the type of pathophysiology and stage of respiratory failure. Status of respiratory drive, respiratory muscle strength, air trapping, parenchymal inflammation, body and lung water and circulatory competence are all relevant. Nutritional support increases metabolic demand and respiratory drive with progressive improvement in respiratory muscle and parenchymal function. Carbohydrate may increase CO2 production and RQ, especially in injured or septic patients, which may result in increased ventilatory demand. Intravenous fat emulsions are an accepted alternative substrate; recent work suggests that their quantity and quality may affect pulmonary vasomotor tone and pulmonary inflammation due to changes in eicosanoid metabolism. These properties may have implications to both severe chronic diseases (i.e. cystic fibrosis) and acute respiratory failure. Amino acid infusions, especially the BCAA-enriched formulas, result in a dose-dependent increase in ventilatory drive and response to hypercapnia; detrimental effects may occur in states with high respiratory drive. In acute phase, calories are supplied in the 1-1.2 REE range; once the patient has stabilized this is increased to 1.4-1.7 REE. Glucose is supplied in the lower range of the obligatory need (2-4 g · kg-1 · day-1) and lipid, which has an equivalent nitrogen-sparing effect, is infused 12-24 h daily to provide 50-60% of daily calories. Amino acids are infused at 1-2 g protein · kg-1 · day-1. A good response to a proper nutritional regimen in respiratory insufficiency is accompanied by diuresis and a rise in serum albumin in addition to normalization of respiratory drive and muscle endurance.

AB - Malnutrition has a well defined effect on pulmonary physiology and pulmonary dysfunction may lead to nutritional depletion. Nutritional support is used as a part of the routine therapeutic armamentarium for patients with acute and chronic respiratory insufficiency. Since nutrients have pharmacologic properties and physiologic actions, these have to be considered, and tailored to the type of pathophysiology and stage of respiratory failure. Status of respiratory drive, respiratory muscle strength, air trapping, parenchymal inflammation, body and lung water and circulatory competence are all relevant. Nutritional support increases metabolic demand and respiratory drive with progressive improvement in respiratory muscle and parenchymal function. Carbohydrate may increase CO2 production and RQ, especially in injured or septic patients, which may result in increased ventilatory demand. Intravenous fat emulsions are an accepted alternative substrate; recent work suggests that their quantity and quality may affect pulmonary vasomotor tone and pulmonary inflammation due to changes in eicosanoid metabolism. These properties may have implications to both severe chronic diseases (i.e. cystic fibrosis) and acute respiratory failure. Amino acid infusions, especially the BCAA-enriched formulas, result in a dose-dependent increase in ventilatory drive and response to hypercapnia; detrimental effects may occur in states with high respiratory drive. In acute phase, calories are supplied in the 1-1.2 REE range; once the patient has stabilized this is increased to 1.4-1.7 REE. Glucose is supplied in the lower range of the obligatory need (2-4 g · kg-1 · day-1) and lipid, which has an equivalent nitrogen-sparing effect, is infused 12-24 h daily to provide 50-60% of daily calories. Amino acids are infused at 1-2 g protein · kg-1 · day-1. A good response to a proper nutritional regimen in respiratory insufficiency is accompanied by diuresis and a rise in serum albumin in addition to normalization of respiratory drive and muscle endurance.

UR - http://www.scopus.com/inward/record.url?scp=0025338641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025338641&partnerID=8YFLogxK

M3 - Conference contribution

SN - 0444811613

SP - 131

EP - 136

BT - Nutritional support in organ failure: proceedings of the International Symposium. ICS836

A2 - Tanaka, T.

A2 - Okada, A.

A2 - Tanaka, T.

A2 - Okada, A.

PB - Elsevier Science Publishers B.V.

ER -